Immunovant Inc. (IMVT)
Market Closed
3 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
39. 12
-0.37
-0.9369%
$
8.43B Market Cap
- P/E Ratio
- Div Yield
1.24M Volume
-1.77 Eps
$ 39.49
Previous Close 
Want to track IMVT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Immunovant Inc. (IMVT) Statistics
Valuation metrics
Market Cap 8.43B
Enterprise value 7.71B
Trailing P/E (ttm) -14.61
Forward P/E -
PEG ratio -22.58
Price/Sales (ttm) 1,198.56
Price/Book (mrq) 11.52
Enterprise Value/Revenue 1,086.11
Enterprise Value/EBITDA -14.31
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.03M
Average volume (90 days) 1.21M
Price summary
52-Week low 14.58
52-Week high 45.42
Beta -
50-Day moving average 41.41
200-Day moving average 29.38
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -75.86%
Operating margin -78.77%
Operational effectiveness
Return on assets -0.63%
Return on equity -0.7%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.62
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.88
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 7.27%
Book value per share (mrq) 3.58
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
